Matthew Fuller
Login to view DISC.Matthew is a PhD-level molecular biologist and virologist with over 17 years of experience. As the Head of Gene Therapy Research at Ultragenyx, he leads a cross-functional team of 40 researchers focused on optimizing gene therapy platforms for liver, CNS, and muscle programs.
Outside of his primary role, Matthew is deeply committed to advancing cures for rare diseases. He volunteers extensively as a member of the scientific advisory boards for several patient advocacy groups, including the Coalition to Cure CHD2, IDefine, and the Myhre Syndrome Foundation.
He serves as the Chief Scientific Advisor for the Cohen Syndrome Association, highlighting his dedication to specific rare disease communities.
Read the full overview →How Matthew shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Matthew cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Ultragenyx Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.